Immunotherapy Market Size, Share, Growth Drivers, Trends & Opportunities by 2027

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Market Estimation
1.4. Market Forecasting

2. Executive Summary

3. Market Overview
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunities
3.1.4. Key Market Trends
3.2. Industry Speaks

4. Snapshot: Key Emerging Immunotherapy Companies

5. Global Immunotherapy Market - Size & Forecast (2019-2027), By Product Type
5.1. Monoclonal Antibodies
5.2. Vaccines
5.3. Checkpoint Inhibitors
5.4. Cell Therapies
5.5. Immunomodulators
5.6. Other Product Types

6. Global Immunotherapy Market - Size & Forecast (2019-2027), By Application
6.1. Prostate Cancer
6.2. Breast Cancer
6.3. Skin Cancer
6.4. Lung Cancer
6.5. Other Applications

7. Global Immunotherapy Market - Size & Forecast (2019-2027), By End User
7.1. Hospitals and Clinics
7.2. Cancer Research Centres
7.3. Other End Users

8. Global Immunotherapy Market - Size & Forecast (2019-2027), By Region
8.1. North America (U.S. & Canada)
8.2. Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
8.3. Asia Pacific (China, India, Japan, Rest of Asia Pacific)
8.4. Rest of the World (Latin America, Middle East & Africa)

9. Competitive Landscape
9.1. Key Players and their Competitive Positioning
9.1.1. Competitive Positioning of Key Players (2022)
9.1.2. Offerings Assessment, By Players
9.2. Key Strategies Assessment, By Player (2021-2023)
9.2.1. New Product & Service Launches
9.2.2. Partnerships, Agreements, & Collaborations
9.2.3. Mergers & Acquisitions
9.2.4. Geographic Expansion

10. Key Companies Scanned (Indicative List)
10.1. Amgen Inc.
10.2. Bayer AG
10.3. Astellas Pharma Inc.
10.4. AstraZeneca
10.5. Bristol-Myers Squibb
10.6. F. Hoffmann-La Roche
10.7. Pfizer Inc.
10.8. Eli Lily and Company
10.9. Novartis AG
10.10. Johnson & Johnson (Janssen Global Services LLC)
10.11. Merck and Co.Inc.
10.12. Other Key Players